The goal of the Traditional IGNITE awards program is to advance understanding of female-specific and sex-differentiated effects in novel therapeutics among a subject matter of the applicant’s expertise.
One $50,000 award will be distributed. The award total is inclusive of indirect costs. Applicants must have an HMS appointment and BWH listed as the primary affiliation.
The 2022 application cycle for this award is currently open. Please note the important deadlines below:
Letter of Intent due: November 8, 2021
Full proposals due: January 15, 2022
To access the full RFP and other application materials, please visit our funding opportunities page.
This award is funded by Jennifer Toolin McAuliffe and other generous donors of our BWH Women’s Health Advisory Board.